Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Lincoln Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:531633NSE Symbol: LINCOLNP/E(TTM):12.43
ISIN Demat:INE405C01035Div & Yield %:0.36EPS(TTM):39.94
Book Value(Rs):357.3529446Market Cap ( Cr.):994.68Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 623.23580.55510.31472.08422.91376.09
Excise Duty0.000.000.000.000.000.00
Net Sales623.23580.55510.31472.08422.91376.09
Other Income 22.4834.4222.4810.005.7412.13
Stock Adjustments -8.845.704.2413.57-3.675.86
Total Income636.87620.67537.03495.65424.98394.08
EXPENDITURE :      
Raw Materials 282.48284.04245.64232.15193.26192.63
Power & Fuel Cost11.6611.4710.258.337.107.57
Employee Cost 112.45102.9093.1679.7263.2054.90
Other Manufacturing Expenses 27.9323.7019.5516.6116.2714.35
Selling and Administration Expenses 75.2860.9954.5050.8850.8049.58
Miscellaneous Expenses 3.103.242.282.501.583.54
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure512.90486.34425.39390.18332.20322.57
Operating Profit123.97134.33111.65105.4792.7871.50
Interest 1.881.462.031.451.551.98
Gross Profit122.09132.87109.62104.0291.2369.52
Depreciation12.9010.629.178.097.565.47
Profit Before Tax109.19122.25100.4595.9383.6764.05
Tax25.3325.4425.9725.8521.1714.72
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax1.523.491.590.720.25-0.24
Reported Net Profit82.3593.3072.9069.3562.2549.56
Extraordinary Items 1.311.070.370.61-0.09-0.03
Adjusted Net Profit81.0492.2372.5368.7462.3449.59
Adjst. below Net Profit 0.000.000.000.000.00-0.62
P & L Balance brought forward507.46417.66348.26282.41220.66170.09
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 4.113.503.503.500.507.12
P & L Balance carried down585.70507.46417.66348.26282.41211.92
Dividend0.000.000.000.000.003.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %18.0018.0015.0015.0015.0015.00
Earnings Per Share-Unit Curr41.1146.5836.4034.6331.0824.78
Earnings Per Share(Adj)-Unit Curr41.1146.5836.4034.6331.0824.78
Book Value-Unit Curr335.34295.98250.86216.12182.92152.25